Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2022-10-28 | 2022-12-15 | 173031 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2021-10-21 | 2022-01-07 | 147702 |
| TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 974 |
| TEVA-CAPECITABINE | 500MG | TABLET | Resolved | 2017-04-25 | 2017-05-23 | 8062 |
| TEVA-CAPECITABINE | 150MG | TABLET | Resolved | 2017-08-01 | 2018-05-11 | 17862 |
| TEVA-CAPTOPRIL | 12.5MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162286 |
| TEVA-CAPTOPRIL | 100MG | TABLET | Resolved | 2019-09-19 | 2020-03-19 | 94378 |
| TEVA-CAPTOPRIL | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138303 |
| TEVA-CAPTOPRIL | 25MG | TABLET | Resolved | 2019-10-31 | 2020-01-09 | 97611 |
| TEVA-CAPTOPRIL | 50MG | TABLET | Actual shortage | 2025-07-03 | 2025-07-03 | 261773 |
| TEVA-CAPTOPRIL | 50MG | TABLET | Resolved | 2021-07-08 | 2021-07-16 | 142210 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2021-05-20 | 2021-05-27 | 139728 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-04-25 | 2019-05-28 | 82410 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2025-08-14 | 2025-12-02 | 265217 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2017-03-13 | 2019-05-28 | 983 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-06-18 | 2019-12-19 | 86859 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2024-06-13 | 2024-11-18 | 230316 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-06-18 | 2019-12-19 | 86879 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183380 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2020-04-10 | 2020-05-01 | 111803 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258522 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258409 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258412 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258405 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258400 |
| TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258396 |
| TEVA-ONDANSETRON | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258774 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258729 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258433 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258430 |